Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Spurred By Demand For Global And Regional Trials In India, China And Japan, ICON Charts Asia Growth Strategy

This article was originally published in PharmAsia News

Executive Summary

SINGAPORE - Malcolm Burgess, Executive VP Asia Pacific with Ireland-headquartered ICON Plc - one of the fastest growing contract research organizations in Asia - expresses satisfaction that over the past seven years he could develop a close bonding with his 600 plus staffers based in the medium-sized cities of Chennai and Thiruvananthapuram at the southern tip of India
Advertisement

Related Content

ICON Goes Local As China CRO Market Heats Up
Korea's Celltrion Deepens Cooperation With PPD For Entire Biosimilar Portfolio
Korea's Celltrion Deepens Cooperation With PPD For Entire Biosimilar Portfolio
Change Of Guard At Quintiles India As Company Continues Aggressive Asia Efforts With Samsung Deal
Change Of Guard At Quintiles India As Company Continues Aggressive Asia Efforts With Samsung Deal
Japan's Improved Clinical Trial Requirements Bring Positive Impact To China, Korea Development
ICON Opens New Asian Offices To Keep Pace With Growing Demand For More Trials In Emerging Markets
Advertisement
UsernamePublicRestriction

Register

SC078114

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel